An aging population, innovation and market expansion to India and China will likely help drive growth for eye-care product firms such as Alcon and Allergan, a Citi Investment Research analyst says. The ophthalmology sector, worth about $21 billion, has outperformed the overall market and is still seeing favorable trends, the analyst added.

Related Summaries